Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.
about
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsCritical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic StressRepression of GSK3 restores NK cell cytotoxicity in AML patients.The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cellsLoss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing.Survival in acute myeloid leukemia is associated with NKp44 splice variants.Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells.Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?Exploiting natural killer group 2D receptors for CAR T-cell therapy.Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.Monocyte chemoattractant protein 1 (MCP-1/CCL2) contributes to thymus atrophy in acute myeloid leukemia.Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progressionNK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions.KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patients.The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells.Patient's Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers.The progress and current status of immunotherapy in acute myeloid leukemia.Advances in immunotherapy for pediatric acute myeloid leukemia.Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
P2860
Q26751011-7B0470E8-1EEF-4C1D-952E-8F35A1A1923AQ26781260-5C769EE3-9C31-4F3C-8CB6-C1AA408B438CQ36768725-3BDDC82E-89C4-4BAB-874A-2FF8FAE2143CQ37222069-EFF0ECFA-6A4D-4B4F-AB43-380054ADD0BAQ37224591-0980F72B-EC15-4FA6-ADE9-381911F22C7EQ37362807-89208A03-8397-4DBD-AD51-2F8F5989F55CQ37620061-1A252BA4-E07F-4133-9D5C-64F1A7A4B9FFQ38522618-EE271FC1-6E65-43ED-947A-D7EA80015F87Q38671184-4250074E-584A-4837-940C-281911A88FD9Q38841469-6E2E1202-C91D-4CA5-96E7-879C7769F629Q39100783-805245EA-1220-43FB-A5D1-089080CA5B93Q39136762-8F914191-52B1-4DC0-BA52-9030AC0AC983Q40296275-F3DB2F87-8600-4C85-B715-83FF7E09B3D6Q41065103-35FA204A-AD09-416F-99ED-423C023B5B0DQ41348806-D6B85A23-B19B-4C98-9AA8-38A4D5B5D379Q42209070-E6DA6CD5-667C-4844-9560-E540FB259322Q47590707-A1643DC2-D72E-4FC9-88FE-7C2EB370E05BQ47930962-4EEE6025-D80C-42BB-915F-A29349D4FC9AQ54204985-1F12953A-C49D-4301-9871-DD15983F109B
P2860
Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Acute myeloid leukemia impairs ...... totoxic immunological synapse.
@en
type
label
Acute myeloid leukemia impairs ...... totoxic immunological synapse.
@en
prefLabel
Acute myeloid leukemia impairs ...... totoxic immunological synapse.
@en
P2093
P2860
P356
P1476
Acute myeloid leukemia impairs ...... ytotoxic immunological synapse
@en
P2093
Emmanuel Raffoux
Guylaine Henry
Hervé Dombret
Niclas Setterblad
Nicolas Boissel
Sophie Agaugue
Zena Khaznadar
P2860
P304
P356
10.1002/EJI.201444500
P407
P577
2014-09-04T00:00:00Z